Induced pluripotent stem cells in disease modelling and drug discovery

RG Rowe, GQ Daley - Nature Reviews Genetics, 2019 - nature.com
The derivation of induced pluripotent stem cells (iPSCs) over a decade ago sparked
widespread enthusiasm for the development of new models of human disease, enhanced …

Gelatin methacrylate (GelMA)-based hydrogels for cell transplantation: an effective strategy for tissue engineering

S Xiao, T Zhao, J Wang, C Wang, J Du, L Ying… - Stem cell reviews and …, 2019 - Springer
Gelatin methacrylate (GelMA)-based hydrogels are gaining a great deal of attention as
potentially implantable materials in tissue engineering applications because of their …

A decade of transcription factor-mediated reprogramming to pluripotency

K Takahashi, S Yamanaka - Nature reviews Molecular cell biology, 2016 - nature.com
The past 10 years have seen great advances in our ability to manipulate cell fate, including
the induction of pluripotency in vitro to generate induced pluripotent stem cells (iPSCs). This …

Emerging frontiers in drug delivery

MW Tibbitt, JE Dahlman, R Langer - Journal of the American …, 2016 - ACS Publications
Medicine relies on the use of pharmacologically active agents (drugs) to manage and treat
disease. However, drugs are not inherently effective; the benefit of a drug is directly related …

In vitro Models of Neurodegenerative Diseases

A Slanzi, G Iannoto, B Rossi, E Zenaro… - Frontiers in cell and …, 2020 - frontiersin.org
Neurodegenerative diseases are progressive degenerative conditions characterized by the
functional deterioration and ultimate loss of neurons. These incurable and debilitating …

Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids

BS Freedman, CR Brooks, AQ Lam, H Fu… - Nature …, 2015 - nature.com
Abstract Human-pluripotent-stem-cell-derived kidney cells (hPSC-KCs) have important
potential for disease modelling and regeneration. Whether the hPSC-KCs can reconstitute …

Pluripotent stem cells in disease modelling and drug discovery

Y Avior, I Sagi, N Benvenisty - Nature reviews Molecular cell biology, 2016 - nature.com
Experimental modelling of human disorders enables the definition of the cellular and
molecular mechanisms underlying diseases and the development of therapies for treating …

Organ-on-a-chip devices advance to market

B Zhang, M Radisic - Lab on a Chip, 2017 - pubs.rsc.org
To curb the high cost of drug development, there is an urgent need to develop more
predictive tissue models using human cells to determine drug efficacy and safety in advance …

A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome

FK Wiseman, T Al-Janabi, J Hardy… - Nature Reviews …, 2015 - nature.com
Down syndrome, which arises in individuals carrying an extra copy of chromosome 21, is
associated with a greatly increased risk of early-onset Alzheimer disease. It is thought that …

Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies

G Wang, ML McCain, L Yang, A He, FS Pasqualini… - Nature medicine, 2014 - nature.com
Study of monogenic mitochondrial cardiomyopathies may yield insights into mitochondrial
roles in cardiac development and disease. Here, we combined patient-derived and …